Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02903914 |
|---|---|
| Brief Title: | Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors |
| First Submitted : | September 9, 2016 |
| First Submitted that Met QC Criteria : | September 13, 2016 |
| First Posted : | September 16, 2016 (Estimate) |
| Results First Submitted : | August 31, 2021 |
| Results First Submitted that Met QC Criteria : | August 31, 2021 |
| Results First Posted : | September 30, 2021 |
| Last Update Submitted that Met QC Criteria : | February 22, 2023 |
| Last Update Posted : | February 24, 2023 |